Stryker Corporation (NYSE:SYK) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Stryker Corporation (NYSE:SYK) have been given an average recommendation of “Moderate Buy” by the twenty-four brokerages that are covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation, seventeen have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $386.28.

Several research firms recently issued reports on SYK. Barclays dropped their price target on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. Canaccord Genuity Group decreased their price objective on Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Stryker in a research note on Friday, May 1st. UBS Group started coverage on Stryker in a research report on Tuesday, July 28th. They set a “buy” rating and a $400.00 target price for the company. Finally, Argus set a $370.00 price target on Stryker in a research note on Thursday, July 9th.

Insider Activity

In related news, insider Debra King sold 826 shares of Stryker stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the transaction, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. This trade represents a 11.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 50,000 shares of Stryker stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the transaction, the director directly owned 2,251,375 shares of the company’s stock, valued at $765,692,637.50. This represents a 2.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 355,370 shares of company stock worth $119,447,201. Corporate insiders own 4.60% of the company’s stock.

Institutional Trading of Stryker

Several hedge funds have recently modified their holdings of SYK. Sankala Group LLC bought a new stake in Stryker during the 4th quarter worth approximately $26,000. Godfrey Financial Associates Inc. bought a new position in Stryker in the 4th quarter valued at $26,000. United Financial Planning Group LLC bought a new position in Stryker in the 3rd quarter valued at $27,000. Atlas Capital Advisors Inc. acquired a new position in Stryker in the fourth quarter worth $27,000. Finally, Gables Capital Management Inc. acquired a new position in Stryker in the second quarter worth $25,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Stryker Trading Up 1.0%

Shares of Stryker stock opened at $331.06 on Friday. The firm has a market capitalization of $126.98 billion, a PE ratio of 34.31, a price-to-earnings-growth ratio of 2.09 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The company’s fifty day moving average price is $327.80 and its two-hundred day moving average price is $331.95. Stryker has a 52-week low of $281.00 and a 52-week high of $396.86.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The company had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. During the same period last year, the firm earned $3.13 EPS. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, analysts expect that Stryker will post 15.02 EPS for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker’s dividend payout ratio (DPR) is presently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.